News & Articles

Across all populations, BNT162b2 administration was well tolerated with mild to moderate fever in fewer than 20% of the participants

Regeneron will distribute REGN-COV2 in the U.S. and Roche will be responsible for distribution outside the U.S.

The AccuPlex SARS-CoV-2 molecular controls kit is designed to measure day-to-day assay performance and contains positive materials

The collaboration is the first larger scale production run of Apta-1 as a non-GMP material, intended for use in GLP toxicology studies

The test outperforms other molecular tests with a low detection limit of 15 GEC/reaction (250 GEC/ml of sample) and a robust control system

The consortium aims to determine the dynamics, function and potential for therapeutic intervention of the RNA and protein structures of SARS-CoV-2

IgM assay has 95.51% positive predictive value even when disease incidence is only 3%

The new assays are designed to enable turnaround times for next-generation sequencing results of less than 24 hours

Used to empower clinicians to quickly prescribe treatment regimens for multidrug-resistant TB, the test could help fill a critical gap that is jeopardizing global TB targets

Connecting the scientific community with two new online content-packed events

Nirsevimab is the first potential passive immunisation for infants to demonstrate sustained protection across the entire RSV season with a single dose

In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of disease severity, including Types 1, 2, and 3 SMA

The high-throughput system enables laboratories to double or even triple their testing capacity

The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings

BD Kiestra InoqulA system is available in Europe (CE marked)

This powerful new solution aims to provide more accurate COVID-19 antibody detection

Catch up on this expert on-demand webinar to discover a novel approach for in silico method development and robustness assessment

Join us on Tuesday, August 11, to learn about a novel serological platform used for COVID-19 testing

Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing

BLENREP is the fifth major medicine approval for GSK in 2020

Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes

The modular solution aims to deliver test results in a four-step process requiring minimal hands-on time, laboratory space and staffing resources

Exclusive interviews, new methods, free downloads, and much more to help you advance your work

Watch this on-demand webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine